One of Canada’s cannabis industry leaders, Delta 9 Cannabis Inc. (TSX:DN) recently released its Q2 and 6-month numbers for 2022. But investors may be much more interested in looking ahead to future operational growth versus looking back at the previous results.

Delta 9 Cannabis - CEO, John Arbuthnot.
Source: Delta 9 Cannabis.

Click here for the full story.


Weekly Update – Top Cannabis News Stories

1 | Top Story: High Tide (TSXV:HITI) finalizes Choom acquisition

2 | Adastra Holdings (CSE:XTRX) receives Controlled Drugs and Substances Dealer’s License

3 | Leviathan Natural (CSE:EPIC) completes sale of Woodstock Biomed

4 | Juva Life (CSE:JUVA) reports 144 per cent increase in revenue for Q2, 2022

5 | Bhang (CSE:BHNG) partners with Hoodie Analytics

Top Cannabis Stocks August 26 to September 1, 2022

1. T.WEED | 13,575 views | Canopy Growth Stock.
2. T.HEXO |8,727 views | HEXO Corp.
3. TLRY | 7,220 views | Tilray Brands Inc.
4. C.TNY | 3,809 views | Tinley Beverage Co. Inc.
5. V.LFST | 3,616 views | Lifeist Wellness Inc.
6. C.OILS | 3,288 views | Nextleaf Solutions Ltd.

New to investing in Cannabis? Check out these tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit the Cannabis Bullboards page.


More From The Market Online
Market graph

@ the Bell: Markets hover near all-time highs

A surge in commodity prices helped lift markets trading in Canada’s busiest centre on Friday to nearly reach a new all-time high.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.